OTC - ACTIVE INGREDIENT SECTION
Glycerin 0.9%
Optase MGD Advanced Dry Eye Drops
- Manufacturer
- Scope Health Inc | Oy Finnsusp Ab
- Effective date
- 2026-01-30
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- full-release
- Hydrated at
- 2026-06-01 01:36:03
Label at a glance#
ProductOptase
Active ingredientGLYCERIN
Label structure9 sections
Label contents#
Full prescribing information#
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep Out of Reach of Children
If swallowed, get medical help or contact a poison control center right away.
OTC - PURPOSE SECTION
Eye Lubricant
WARNINGS SECTION
Warning
• For external use only.
• To avoid contamination, do not touch tip
of container to any surface. After use, shake the bottle
downwards in order to remove any residual drop that
may be left. Replace cap after using.
• Do not use the solution if it changes color or becomes
cloudy
Stop use and ask doctor if
• You feel eye pain.
• Changes in vision occur.
• Redness or irritation of the eye lasts.
• Condition worsens or lasts more than 72 hours.
INDICATIONS & USAGE SECTION
Uses
• For use as a lubricant to prevent further irritation.
• May be used as a protectant against further irritation.
• To relieve dryness of the eye.
DOSAGE & ADMINISTRATION SECTION
Directions
Put one or two drops in the affected eyes as needed.
INACTIVE INGREDIENT SECTION
Citric Acid Monohydrate, Polyoxyethylenesorbitan Monooleate, Potassium Chloride, Purified Water, Saccha Inchi Seed Oil, Sodium Hyaluronate , Sorbitan Monooleate, Trehalose, Tromethamine
Insert/Instructions- Page 1
Insert/Instructions Page 2
Optase MGD Advanced Eye Drops
Immediate label
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| GLYCERIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0860004006831 | GTIN-13: 0860004006831 EAN-13: 0860004006831 GTIN-12: 860004006831 UPC-A: 860004006831 GTIN storage (14 digits): 00860004006831 | OPTASE MGD Advanced Eye Drop Box 2025 (P).jpg |
| QR code link | QR Code |  optase.com/how-to-get-the-best-results/ | OPTASE MGD Advanced Eye Drop Box 2025 (P).jpg |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72972-004-01 | Optase | 10 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 10 | 5 | |
| 72972-004-01 | Optase | 1 in 1 BOX | SOLUTION/ DROPS | 1 | 5 |
Products#
Every source-derived product name is available through these pages.
- Optase
- glycerin
- POLYSORBATE 80
- TREHALOSE
- HYALURONATE SODIUM
- CITRIC ACID MONOHYDRATE
- WATER
- TROMETHAMINE
- SORBITAN MONOOLEATE
- POTASSIUM CHLORIDE
- PLUKENETIA VOLUBILIS SEED OIL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72972-004 | 72972-004-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| TREHALOSE | B8WCK70T7I | IACT |
| GLYCERIN | PDC6A3C0OX | ACTIB |
| HYALURONATE SODIUM | YSE9PPT4TH | IACT |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| WATER | 059QF0KO0R | IACT |
| TROMETHAMINE | 023C2WHX2V | IACT |
| SORBITAN MONOOLEATE | 06XEA2VD56 | IACT |
| POTASSIUM CHLORIDE | 660YQ98I10 | IACT |
| PLUKENETIA VOLUBILIS SEED OIL | 8ED72Z8J1Z | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | 72972-004-01 72972-004 72972000401 49a62bc6-5b72-db88-e063-6294a90ae6cc d81c1a4f-87b0-ee8c-e053-2995a90af9e5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.